AusperBio has raised $37m in a Series A financing round to propel the clinical development of AHB-1 for chronic hepatitis B (CHB). The funding round was spearheaded by existing investor the ...
SAN FRANCISCO, May 7, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced the presentation of ...
Embedded system designers have a choice of using a shared or point-to-point bus in their designs. Typically, an embedded design will have a general purpose processor, cache, SDRAM, DMA port, and ...
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) ...
CAMBRIDGE, UK – July 23, 2003 – ARM [(LSE:ARM); (Nasdaq:ARMHY)], the industry's leading provider of 16/32-bit embedded RISC processor solutions, today announced the availability for download of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results